{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "Y",
                    "alt": "C",
                    "position": "1699"
                },
                "variant_string_id": "LRRK2 Y1699C"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "LRRK2 mutants have been linked to the onset of parkinsonian symptoms. Based on structural and domain analysis, LRRK2 is predicted to function as a stress - responsive protein scaffold mediating the regulation of mitogen - activating protein kinase (MAPK) pathways. Cells expressing LRRK2 mutants suffer a loss of protection normally derived from wild - type LRRK2, making them more vulnerable to oxidative stress.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the link between LRRK2 mutants and parkinsonian symptoms and describes the predicted function of LRRK2 in stress - related MAPK pathways, thus defining the disease mechanism relevant to the functional assay.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used assays like cell viability (WST - 1 assay, cell count post - stained with Hoechst stain), necrosis (LDH assay), and immunoblot analysis to study the impact of wild - type LRRK2 and mutants on cell viability and activation of ERK1/2 pathway in response to H₂O₂ - induced oxidative stress.",
                    "judgment": "Yes",
                    "reasoning": "These assays effectively model the disease - relevant oxidative stress response and the role of LRRK2 in the MAPK pathway as defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All values in the figures were calculated from at least 2 - 3 independent experiments with each experiment containing at least 6 - 8 replicates in each experimental condition. Results are reported as mean value ± SEM. The significance of difference between means was assessed by ANOVA and post hoc Fisher's protected least significant difference (PLSD) tests, with p<0.05 considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The paper states that multiple replicates were used, and basic statistical controls are in place, fulfilling the requirements of basic controls and replicates.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of Y1699C and G2019S mutants with wild - type LRRK2, and wild - type LRRK2 can be considered a control. Also, the study mentions that different LRRK2 mutants have different inherent kinase activity, and some mutants have lower kinase activity than the wild - type counterpart.",
                    "judgment": "Yes",
                    "reasoning": "Wild - type LRRK2 is used as a control, fulfilling the condition of variant controls.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Results are reported as mean value ± SEM. The significance of difference between means was assessed by ANOVA and post hoc Fisher's protected least significant difference (PLSD) tests, with p<0.05 considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The use of ANOVA and post - hoc tests indicates that statistical analyses are sufficient to estimate or calculate OddsPath for the functional data.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The paper does not directly report OddsPath values. But considering the statistical significance shown through ANOVA and post - hoc tests, and the clear differences in cell viability and ERK activation between wild - type and Y1699C mutant, it can be inferred that there is a significant impact of the mutation. However, without an explicit OddsPath value, we cannot precisely classify the strength. But based on the clear functional differences, we can consider it at least supporting evidence.",
                    "judgment": "N/A",
                    "reasoning": "No explicit OddsPath value, but significant functional differences suggest supporting evidence.",
                    "next_step_or_outcome": "PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The Y1699C variant in LRRK2 was studied in the context of parkinsonian - related oxidative stress response. The assay methods were applicable, basic controls and replicates were present, variant controls were used, and statistical analyses were sufficient. Although no explicit OddsPath was given, the significant functional differences between wild - type and the mutant suggest PS3_supporting evidence for the pathogenicity of the Y1699C variant."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "S",
                    "position": "2019"
                },
                "variant_string_id": "LRRK2 G2019S"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "LRRK2 mutants have been linked to the onset of parkinsonian symptoms. Based on structural and domain analysis, LRRK2 is predicted to function as a stress - responsive protein scaffold mediating the regulation of mitogen - activating protein kinase (MAPK) pathways. Cells expressing LRRK2 mutants suffer a loss of protection normally derived from wild - type LRRK2, making them more vulnerable to oxidative stress.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the link between LRRK2 mutants and parkinsonian symptoms and describes the predicted function of LRRK2 in stress - related MAPK pathways, thus defining the disease mechanism relevant to the functional assay.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study used assays like cell viability (WST - 1 assay, cell count post - stained with Hoechst stain), necrosis (LDH assay), and immunoblot analysis to study the impact of wild - type LRRK2 and mutants on cell viability and activation of ERK1/2 pathway in response to H₂O₂ - induced oxidative stress.",
                    "judgment": "Yes",
                    "reasoning": "These assays effectively model the disease - relevant oxidative stress response and the role of LRRK2 in the MAPK pathway as defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All values in the figures were calculated from at least 2 - 3 independent experiments with each experiment containing at least 6 - 8 replicates in each experimental condition. Results are reported as mean value ± SEM. The significance of difference between means was assessed by ANOVA and post hoc Fisher's protected least significant difference (PLSD) tests, with p<0.05 considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The paper states that multiple replicates were used, and basic statistical controls are in place, fulfilling the requirements of basic controls and replicates.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "The study compared the effects of G2019S and Y1699C mutants with wild - type LRRK2, and wild - type LRRK2 can be considered a control. Also, the study mentions that different LRRK2 mutants have different inherent kinase activity, and some mutants have lower kinase activity than the wild - type counterpart.",
                    "judgment": "Yes",
                    "reasoning": "Wild - type LRRK2 is used as a control, fulfilling the condition of variant controls.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Results are reported as mean value ± SEM. The significance of difference between means was assessed by ANOVA and post hoc Fisher's protected least significant difference (PLSD) tests, with p<0.05 considered statistically significant.",
                    "judgment": "Yes",
                    "reasoning": "The use of ANOVA and post - hoc tests indicates that statistical analyses are sufficient to estimate or calculate OddsPath for the functional data.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The paper does not directly report OddsPath values. But considering the statistical significance shown through ANOVA and post - hoc tests, and the clear differences in cell viability between wild - type and G2019S mutant, it can be inferred that there is a significant impact of the mutation. However, without an explicit OddsPath value, we cannot precisely classify the strength. But based on the clear functional differences, we can consider it at least supporting evidence.",
                    "judgment": "N/A",
                    "reasoning": "No explicit OddsPath value, but significant functional differences suggest supporting evidence.",
                    "next_step_or_outcome": "PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The G2019S variant in LRRK2 was studied in the context of parkinsonian - related oxidative stress response. The assay methods were applicable, basic controls and replicates were present, variant controls were used, and statistical analyses were sufficient. Although no explicit OddsPath was given, the significant functional differences between wild - type and the mutant suggest PS3_supporting evidence for the pathogenicity of the G2019S variant."
        }
    ]
}